Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

Nagy A, Schally AV, Armatis P, Szepeshazi K, Halmos G, Kovacs M, Zarandi M, Groot K, Miyazaki M, Jungwirth A, Horvath J.

Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7269-73.

PMID:
8692981
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.

Nagy A, Schally AV.

Biol Reprod. 2005 Nov;73(5):851-9. Epub 2005 Jul 20. Review.

PMID:
16033997
[PubMed - indexed for MEDLINE]
Free Article
3.

Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.

Schally AV, Nagy A.

Eur J Endocrinol. 1999 Jul;141(1):1-14. Review.

PMID:
10407215
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

Antitumor effects of analogs of LH-RH and somatostatin: experimental and clinical studies.

Schally AV, Srkalovic G, Szende B, Redding TW, Janaky T, Juhasz A, Korkut E, Cai RZ, Szepeshazi K, Radulovic S, et al.

J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):1061-7. Review.

PMID:
1981009
[PubMed - indexed for MEDLINE]
6.

New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin.

Schally AV, Nagy A.

Life Sci. 2003 Apr 11;72(21):2305-20. Review.

PMID:
12639697
[PubMed - indexed for MEDLINE]
7.

Chemotherapy targeted to cancers through tumoral hormone receptors.

Schally AV, Nagy A.

Trends Endocrinol Metab. 2004 Sep;15(7):300-10. Review.

PMID:
15350601
[PubMed - indexed for MEDLINE]
8.

Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumors.

Schally AV, Engel JB, Emons G, Block NL, Pinski J.

Curr Drug Deliv. 2011 Jan;8(1):11-25. Review.

PMID:
21034424
[PubMed - indexed for MEDLINE]
9.

[Advances in the study of small peptides in targeted drug delivery system].

Sun Y, Wang C.

Yao Xue Xue Bao. 2008 Oct;43(10):992-6. Review. Chinese.

PMID:
19127861
[PubMed - indexed for MEDLINE]
10.

Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis.

Schally AV.

Peptides. 1999;20(10):1247-62. Review.

PMID:
10573298
[PubMed - indexed for MEDLINE]
11.

LH-RH agonists and antagonists.

Schally AV, Coy DH, Arimura A.

Int J Gynaecol Obstet. 1980;18(5):318-24. Review.

PMID:
6110575
[PubMed - indexed for MEDLINE]
12.

AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.

Engel J, Emons G, Pinski J, Schally AV.

Expert Opin Investig Drugs. 2012 Jun;21(6):891-9. doi: 10.1517/13543784.2012.685128. Review.

PMID:
22577891
[PubMed - indexed for MEDLINE]
13.

[History of clinical studies on hypothalamic hormone analogs in Mexico].

Schally AV, González Bárcena D.

Gac Med Mex. 2006 Jul-Aug;142(4):315-25. Review. Spanish.

PMID:
17022307
[PubMed - indexed for MEDLINE]
14.

Hypothalamic hormones and cancer.

Schally AV, Comaru-Schally AM, Nagy A, Kovacs M, Szepeshazi K, Plonowski A, Varga JL, Halmos G.

Front Neuroendocrinol. 2001 Oct;22(4):248-91. Review.

PMID:
11587553
[PubMed - indexed for MEDLINE]
15.

Peptide analogs in the therapy of prostate cancer.

Schally AV, Comaru-Schally AM, Plonowski A, Nagy A, Halmos G, Rekasi Z.

Prostate. 2000 Oct 1;45(2):158-66. Review.

PMID:
11027415
[PubMed - indexed for MEDLINE]
16.

New approaches to the therapy of various tumors based on peptide analogues.

Schally AV.

Horm Metab Res. 2008 May;40(5):315-22. doi: 10.1055/s-2008-1073142. Review.

PMID:
18491250
[PubMed - indexed for MEDLINE]
17.

[Gonadoliberin. Therapeutic prospects].

Sitruk-Ware R, Le Bouc Y, Gompel A, Mauvais-Jarvis P.

Presse Med. 1984 Mar 3;13(9):553-8. Review. French.

PMID:
6230650
[PubMed - indexed for MEDLINE]
18.

Luteinizing hormone-releasing hormone antagonists.

Mezo G, Manea M.

Expert Opin Ther Pat. 2009 Dec;19(12):1771-85. doi: 10.1517/13543770903410237. Review.

PMID:
19939192
[PubMed - indexed for MEDLINE]
19.

Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH).

Engel JB, Schally AV, Buchholz S, Seitz S, Emons G, Ortmann O.

Arch Gynecol Obstet. 2012 Aug;286(2):437-42. doi: 10.1007/s00404-012-2335-1. Epub 2012 May 4. Review.

PMID:
22555802
[PubMed - indexed for MEDLINE]
20.

Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer.

Schally AV, Comaru-Schally AM, Gonzalez-Barcena D.

Biomed Pharmacother. 1992;46(10):465-71. Review.

PMID:
1363977
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk